Metraipolis › archive › dc_d22d10aa7570
Integrated molecular and ADME-toxicity profiling identifies PGV-5 and HGV-5 as potential agents to counteract multidrug-resistant (MDR) cancer — Europe PMC PMID:41120301
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41120301
- DOI
- 10.1038/s41598-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T04:46:25.239Z
- SHA-256 of the archived text
4956eca783be68ee5785742270ca5f1287b832c2ec76c456da6368e472bf0de7- Stable URL of this page
https://metraipolis.com/documento/dc_d22d10aa7570
How to cite
Integrated molecular and ADME-toxicity profiling identifies PGV-5 and HGV-5 as potential agents to counteract multidrug-resistant (MDR) cancer — Europe PMC PMID:41120301 — Europe PMC (en), https://europepmc.org/article/MED/41120301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d22d10aa7570 (Metraipolis archive dc_d22d10aa7570, sha256 4956eca783be68ee5785742270ca5f1287b832c2ec76c456da6368e472bf0de7)
BibTeX
@misc{dcd22d10aa7570,
title = {Integrated molecular and ADME-toxicity profiling identifies PGV-5 and HGV-5 as potential agents to counteract multidrug-resistant (MDR) cancer — Europe PMC PMID:41120301},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41120301},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d22d10aa7570; sha256 4956eca783be68ee5785742270ca5f1287b832c2ec76c456da6368e472bf0de7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41120301. Agents can read the archived copy with the MCP tool read_document.